The effect of zolendronic acid on the clinical resolution of acute midfoot Charcot foot

Phase 4

Active, not recruiting

• Conditions: Charcot neuroarthropathy in patients with diabetes mellitus; Musculoskeletal - Other muscular and skeletal disorders; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12611000065998
• Lead Sponsor: Pirkanmaa Hospital District

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-01-19
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients with acute unilateral Charcot foot and type I or type II diabetes mellitus

Exclusion Criteria

Serum creatine >400 umol/l

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total immobilisation time in cast[6 months and 1 year]

Secondary Outcome Measures

Name	Time	Method
umber of any surgical procedures of the affected foot during the first year of follow-up. Data is collected prospectively from patient records.[1 year]